Bremelanotide was originally developed as a tanning agent, in the original testing it was noted that sexual arousal and erections occurred as a side effect. In 2007 a Phase III clinical trial was proposed but the Food and Drug Administration voiced serious concerns about the side effect of increased blood pressure. In 2008 Palatin Technologies halted development of Bremelanotide for the treatment of sexual dysfunction. In August of 2009 Palatin announced that a double blind study of 54 volunteers using a subcutaneous injection of Bremelanotide did not experience the side effects of elevated blood pressure that existed with the nasal delivery system. Presently Palatin Technologies is talking with the FDA about the resumption of human Phase 2 clinical trials to evaluate the subcutaneous injection. Based on this information I could not state this will be safe for individuals with diabetes until the clinical trials are completed.
*** All information contained on dLife.com is intended for informational and educational purposes only. Our Expert Q&A is not intended to be a replacement or substitute for consultation with a qualified medical professional or for professional medical advice related to diabetes or another medical condition. Please contact your physician or medical professional with any questions and concerns about your medical condition.
Sign up for FREE dLife Newsletters
Has diabetes made it difficult to get/renew a driver's license?